HOUSTON: When you pass the nondescript sign on Cortez Boulevard for Meridien Research you may wonder what goes on there. Well, there is an interesting answer to that question. Meridien Research is currently one of 90 medical research facilities nationwide that will be conducting a Read More »

PHOENIX: A novel cognitive “stress test” that measures recovery from semantic interference can detect preclinical Alzheimer’s disease (AD) and is sensitive to amyloid deposition, new research shows.

The test is “very sensitive to very early cognitive impairment in older adults. We could see a clear Read More »

DALLAS: A San Antonio company is trying to break into the pharmaceutical market with a new version of an old drug that it believes offers hope to two-legged and four-legged patients diagnosed with incurable or life-altering diseases.

Rapamycin, a drug derived from microbes discovered in Read More »

NEW YORK: Tests on a drug with the potential to stop Alzheimer’s in its tracks are being funded by raffles, pensioners’ donations and a sponsored walk – because the research team cannot find money for pre-clinical safety tests any other way.

The team of researchers led Read More »